Skip to main content

MoneyWorks4Me

The sales declined to Rs. 291.75 millions for the June 2023 quarter as compared to Rs. 311.32 millions during the corresponding quarter last year.A slender decline of -9.79% was recorded to Rs. 53.70  millions from Rs. 59.53 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 80.05 millions from 84.15 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 291.75 311.32 -6.29 291.75 311.32 -6.29 1367.49 1239.80 10.30
Other Income 10.37 11.43 -9.27 10.37 11.43 -9.27 51.23 49.49 3.52
PBIDT 80.05 84.15 -4.87 80.05 84.15 -4.87 354.90 322.04 10.20
Interest 0.74 0.87 -14.94 0.74 0.87 -14.94 3.67 4.35 -15.63
PBDT 79.31 83.28 -4.77 79.31 83.28 -4.77 351.23 317.69 10.56
Depreciation 5.00 5.35 -6.54 5.00 5.35 -6.54 22.59 18.99 18.96
PBT 74.31 77.93 -4.65 74.31 77.93 -4.65 328.64 298.70 10.02
TAX 20.61 18.40 12.01 20.61 18.40 12.01 82.58 75.74 9.03
Deferred Tax 0.59 -0.83 -171.08 0.59 -0.83 -171.08 -2.25 2.96 -176.01
PAT 53.70 59.53 -9.79 53.70 59.53 -9.79 246.06 222.96 10.36
Equity 44.13 45.89 -3.84 44.13 45.89 -3.84 44.13 45.89 -3.84
PBIDTM(%) 27.44 27.03 1.51 27.44 27.03 1.51 25.95 25.98 -0.09
Peers
Company Name CMP
Sun Pharma. Inds. 1899.35
Dr. Reddys Labs. 1377.30
Cipla 1412.60
Lupin 2007.00
Zydus Lifesciences 1205.45
View more..